
I
became aware of MJ Biologics in late 2006. After
contacting some veterinarians who were using the
MJPRRS®
vaccine, I decided to try it on my own. In my practice,
I work with mostly independent producers who are
primarily farrow to finish systems and nearly all
dealing with the effects of PRRS.
I had used conventional killed autogenous vaccines
with only marginal success and little cross protection.
I was frustrated by the unpredictable results of
LVI and did not want to use modified live vaccines.
The MJ Biologics technology is unique because it
provides a mechanism to analyze different viruses
to select immunologically different virus strains
to broaden the protection in the MJPRRS®
vaccine.
In 2007, I used this product in 10 farms that had
a history of repeated clinical PRRS outbreaks in
the past. I began using the vaccine to blanket the
sow herd periodically. We were able to provent prental
losses, stabilize the sow herd and protect them
from outbreaks from new or mutated virus challenges.
The number of farms using the vaccine has continued
to grow and during the last 3 years the vaccine
has been applied in many different situations to
stabilize herds, get back to producing PCR negative
pigs more quickly, and reduce levels viremia.
In 2009 with more product availability we started
to use the vaccine in piglets. We are very pleased
with the unexpected results that we experienced.
In the 20-year history of the PRRS disease I have
never witnessed a product that would accomplish
what MJPRRS®
would do in stopping death loss and clearing the
virus in such a short period of time.
The clinical picture was dramatically and rapidly
improved after vaccination even though some PCR
tests remained positive. The Virus Quantitation
revealed that vaccinates has 100 to 1000 fold LESS
virus in their serum compared to non-vaccinates.
In conjunction with other good production practices,
this technology provides the means to produce a
multi-strain vaccine with a high antigen content
that can reduce the clinical and economic impact
of PRRS in a swine herd. My confidence in this technology
allows me to continue to apply this product in situations
where producers have been dealing with costly effects
of PRRS.
Paul J. Armbrecht, DVM
Lake City Veterinary Service
Lake City, Iowa
|